Oncology Central

Hepatocellular carcinoma risk scores: ready to use in 2015?


Hepatocellular carcinoma (HCC) is one of the most common cancers in the world, with more than 0.6 million deaths annually [1,2]. The incidence of liver cancer is highest in sub-Saharan Africa, and Central and Southeast Asia, where the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is high [1,2]. However, only a proportion of patients with chronic infection of HBV and/or HCV will develop HCC. The lifetime risk of developing HCC from 30 to 75 years, for men and women, was 27.38 and 7.99% in chronic hepatitis B patients, and 23.73 and 16.71% in chronic hepatitis C patients [3].

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.